David J Mazzo's Net Worth
$3.43 Million
Who is David J Mazzo?
David J Mazzo has an estimated net worth of $3.43 Million. This is based on reported shares across multiple companies, which include pSivida LTD, Neuralstem, Inc., LISATA THERAPEUTICS, INC., AVANIR PHARMACEUTICALS, and Regado Biosciences Inc.
SEC CIK
David J Mazzo's CIK is 0001334549
Past Insider Trading and Trends
2018 was David J Mazzo's most active year for acquiring shares with 10 total transactions. David J Mazzo's most active month to acquire stocks was the month of December. 2019 was David J Mazzo's most active year for disposing of shares, totalling 6 transactions. David J Mazzo's most active month to dispose stocks was the month of December. 2018 saw David J Mazzo paying a total of $423,312.00 for 331,150 shares, this is the most they've acquired in one year. In 2015 David J Mazzo cashed out on 550,535 shares for a total of $454,261.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
pSivida LTD (EYPT) Snapshot price: $7.97
InvestorDavid J Mazzo owns 200,083 units of Common Stock which is worth $1,594,661.51.acquired a total of 199,583 shares in pSivida LTD at a cost of $235,999.35.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +19.99% | 33.33K |
$1.95 | $64,999.35 | 200.08K |
Oct 9
| |||
Form 4
| +0.25% | 417 |
—
|
—
| 166.75K |
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +5.27% | 8.33K |
—
|
—
| 166.33K |
Jun 21
| |||
Form 4
| +14.49% | 20K |
$1.77 | $35,400.00 | 158K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
| +14.52% | 17.5K |
—
|
—
| 138K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +24,000.00% | 120K |
$1.13 | $135,600.00 | 120.5K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 27
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neuralstem, Inc. (PALI) Snapshot price: $3.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LISATA THERAPEUTICS, INC. (LSTA) Snapshot price: $3.13
Chief Executive OfficerDavid J Mazzo owns 259,543 units of Common Stock, par value $0.001 per share which is worth $812,369.59 and 174,766 units of Common Stock which is worth $547,017.58. From 2015 to 2024 David J Mazzo acquired a total of 1,658,778 shares in LISATA THERAPEUTICS, INC. at a cost of $390,634.00, David also disposed a total of 478,310 shares of LISATA THERAPEUTICS, INC. equalling to $1,117,197.69.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.58% | -1.03K |
$2.99 | -$3,067.74 | 174.77K |
Jan 11
| |||
Form 4
| +66.93% | 70.48K |
$3.07 | -$72,151.68 | 175.79K |
Jan 9 - Jan 10
| |||
Form 4
| -0.41% | -397.00 |
$3.65 | -$1,449.05 | 96.54K |
Jan 13
| |||
Form 4
| -1.05% | -1.03K |
$3.20 | -$3,296.00 | 96.94K |
Jan 11
| |||
Form 4
| +98.78% | 48.69K |
$3.06 | -$34,621.65 | 97.97K |
Jan 9 - Jan 10
| |||
Form 4
| +12.18% | 80.26K |
$0.50 | $40,129.00 | 739.44K |
Sep 1
| |||
Form 4
| -2.03% | -13.08K |
$0.81 | -$10,641.23 | 631.07K |
Jan 13 - Jan 14
| |||
Form 4
| +103.65% | 327.85K |
$0.91 | -$66,209.74 | 644.15K |
Jan 10 - Jan 11
| |||
Form 4
| +1.65% | 4.85K |
$1.55 | -$52,988.76 | 299.5K |
Jan 13 - Jan 14
| |||
Form 4
| +49.57% | 97.65K |
$1.59 | -$33,988.99 | 294.65K |
Jan 8 - Jan 11
| |||
Form 4
| +21.81% | 33.37K |
$3.33 | -$42,058.04 | 186.38K |
Jan 13 - Jan 14
| |||
Form 4
| -2.87% | -4.52K |
$2.83 | -$12,797.26 | 153.01K |
Jan 8
| |||
Form 4
| +36.76% | 40.7K |
—
|
—
| 151.41K |
Jan 14
| |||
Form 4
| -3.89% | -4.48K |
$4.64 | -$20,777.92 | 110.71K |
Jan 8
| |||
Form 4
| +18.66% | 17.21K |
$8.64 | $148,685.76 | 109.45K |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
| +45.48% | 28.84K |
—
|
—
| 92.24K |
Jan 8
| |||
Form 4
| -23.92% | -17.78K |
$5.13 | -$91,201.14 | 56.55K |
May 18
| |||
Form 4
| -0.92% | -690.00 |
$4.74 | -$3,270.60 | 74.33K |
Apr 25
| |||
Form 4
| -1.00% | -761.00 |
$3.87 | -$2,945.07 | 75.02K |
Jan 25
| |||
Form 4
| +60.42% | 28.54K |
$3.54 | -$16,843.32 | 75.78K |
Jan 9
| |||
Form 4
| -0.96% | -457.00 |
$4.12 | -$1,882.84 | 47.24K |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
| -0.95% | -457.00 |
$5.40 | -$2,467.80 | 47.7K |
Jul 25
| |||
Form 4
| -0.98% | -4.54K |
$0.68 | -$3,090.60 | 458.84K |
Apr 25
| |||
Form 4
| +70.56% | 191.71K |
$0.63 | -$13,289.22 | 463.38K |
Jan 25
| |||
Form 4
| +8.35% | 20K |
$1.40 | $27,922.00 | 259.54K |
Aug 17
| |||
Form 4
| +50.14% | 80K |
—
|
—
| 239.54K |
Jun 2
| |||
Form 4
|
∞
| 159.54K |
$3.48 | -$454,261.80 | 159.54K |
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANIR PHARMACEUTICALS No price found
InvestorDavid J Mazzo owns 168,594 units of Class A Common Stock and 336,394 units of Common Stock.acquired a total of 336,394 shares in AVANIR PHARMACEUTICALS at a cost of $15,590.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.40% | 28.9K |
—
|
—
| 336.39K |
Feb 12
| |||
Form 4
| +14.48% | 38.9K |
—
|
—
| 307.49K |
Feb 14
| |||
Form 4
| +12.57% | 30K |
—
|
—
| 268.59K |
Feb 16
| |||
Form 4
| +14.38% | 30K |
—
|
—
| 238.59K |
Feb 8
| |||
Form 4
| +23.73% | 40K |
—
|
—
| 208.59K |
Feb 18
| |||
Form 4
| +55.25% | 60K |
—
|
—
| 168.59K |
Feb 19
| |||
Form 4
| +110.12% | 56.91K |
—
|
—
| 108.59K |
Feb 21
| |||
Form 4
| +595.13% | 44.25K |
—
|
—
| 51.68K |
Mar 1
| |||
Form 4
|
∞
| 7.43K |
$15.59 |
—
| 7.43K |
Feb 13 - Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regado Biosciences Inc No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||